STUELPNAGEL JOHN R sold TXG

September 3, 2026 · Form 4 insider transaction

STUELPNAGEL JOHN R sold 6,174 shares of 10x Genomics, Inc. at $62.61 per share, a transaction worth $386.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Disposed (sell-side)
Shares
6,174
Price
$62.61
Total value
$386.5K
RoleDirector
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 3, 2026
Filing dateSeptember 8, 2026
Shares owned after328,436
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

This transaction was executed in multiple trades at prices ranging from $62.50 to $62.86. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

View the original Form 4 on SEC EDGAR